Literature DB >> 1700777

Development of the interferon system. I. In chicken cells development in ovo continues on time in vitro.

M J Sekellick1, W J Biggers, P I Marcus.   

Abstract

When confluent monolayers of cells derived from chicken embryos of different gestational age were cultured for several days without a medium change, a condition termed in vitro aging, the cells' developed an increased capacity to express the interferon (IFN) system. The capacity to both produce IFN and to respond to its antiviral action were enhanced up to 1000- and 100-fold, respectively. Remarkably, the programmed development of the IFN system in these cells seemed to continue virtually uninterrupted after monodispersion of the cells and seeding at high cell density. Cells prepared from young embryos required more time to develop the IFN system than cells from older embryos with the yield of IFN, and sensitivity to its action, related directly to the total in ovo and in vitro age of the cells in culture. For example, essentially the same yields of IFN were obtained from cell cultures made from 5-d-old embryos "aged" for 10 d in vitro, as were obtained from 10-d-old embryos whose cells were aged in vitro for 5 d. In contrast, inducibility of 2'-5' oligoadenylate synthetase by IFN and the induction of heat shock genes by elevated temperature are not enhanced with in vitro aging. The programmed development of the IFN system that starts in ovo seems to continue on schedule in vitro, making the development of the IFN system in chick embryo cells appear as a time-dependent process.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1700777     DOI: 10.1007/bf02624475

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol        ISSN: 0883-8364


  31 in total

1.  Virus interference. I. The interferon.

Authors:  A ISAACS; J LINDENMANN
Journal:  Proc R Soc Lond B Biol Sci       Date:  1957-09-12

2.  Preferential modulation of embryonic cell proliferation and differentiation by embryonic interferon.

Authors:  J J Greene; P O Ts'o
Journal:  Exp Cell Res       Date:  1986-12       Impact factor: 3.905

3.  Induction of 2'5'-oligoadenylate synthetase activity and a new protein by chick interferon.

Authors:  L A Ball
Journal:  Virology       Date:  1979-04-30       Impact factor: 3.616

4.  A factor capable of enhancing interferon synthesis.

Authors:  N Kato; H J Eggers
Journal:  Virology       Date:  1969-04       Impact factor: 3.616

5.  Developmentally regulated expression of the interferon system during Syrian hamster embryogenesis.

Authors:  J J Greene; R H Dyer; L C Yang; P O Ts'o
Journal:  J Interferon Res       Date:  1984

Review 6.  Biochemistry of interferons and their actions.

Authors:  P Lengyel
Journal:  Annu Rev Biochem       Date:  1982       Impact factor: 23.643

7.  Purification and characterization of chick interferon induced by viruses.

Authors:  M Kohase; H Moriya; T A Sato; S Kohno; S Yamazaki
Journal:  J Gen Virol       Date:  1986-01       Impact factor: 3.891

8.  Lack of systematic correlation between the interferon mediated antiviral state and the levels of 2-5A synthetase and protein kinase in three different types of murine cells.

Authors:  A G Hovanessian; E Meurs; L Montagnier
Journal:  J Interferon Res       Date:  1981-02

9.  Identification of an interferon in murine placentas.

Authors:  A K Fowler; C D Reed; D J Giron
Journal:  Nature       Date:  1980-07-17       Impact factor: 49.962

10.  Interferon induction by viruses. VI. Reovirus: virion genome dsRNA as the interferon inducer in aged chick embryo cells.

Authors:  T R Winship; P I Marcus
Journal:  J Interferon Res       Date:  1980
View more
  19 in total

1.  Activation of interferon regulatory factor 3 is inhibited by the influenza A virus NS1 protein.

Authors:  J Talon; C M Horvath; R Polley; C F Basler; T Muster; P Palese; A García-Sastre
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

2.  In vitro analysis of virus particle subpopulations in candidate live-attenuated influenza vaccines distinguishes effective from ineffective vaccines.

Authors:  Philip I Marcus; John M Ngunjiri; Margaret J Sekellick; Leyi Wang; Chang-Won Lee
Journal:  J Virol       Date:  2010-08-25       Impact factor: 5.103

3.  A highly attenuated measles virus vaccine strain encodes a fully functional C protein.

Authors:  Yuichiro Nakatsu; Makoto Takeda; Masaharu Iwasaki; Yusuke Yanagi
Journal:  J Virol       Date:  2009-09-02       Impact factor: 5.103

4.  Attenuation of equine influenza viruses through truncations of the NS1 protein.

Authors:  Michelle Quinlivan; Dmitriy Zamarin; Adolfo García-Sastre; Ann Cullinane; Thomas Chambers; Peter Palese
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

5.  Influenza A and B viruses expressing altered NS1 proteins: A vaccine approach.

Authors:  J Talon; M Salvatore; R E O'Neill; Y Nakaya; H Zheng; T Muster; A García-Sastre; P Palese
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-11       Impact factor: 11.205

6.  Chimeric influenza A viruses with a functional influenza B virus neuraminidase or hemagglutinin.

Authors:  Astrid Flandorfer; Adolfo García-Sastre; Christopher F Basler; Peter Palese
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

7.  Newcastle disease virus V protein is a determinant of host range restriction.

Authors:  Man-Seong Park; Adolfo García-Sastre; Jerome F Cros; Christopher F Basler; Peter Palese
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

8.  Replication of modified vaccinia virus Ankara in primary chicken embryo fibroblasts requires expression of the interferon resistance gene E3L.

Authors:  Simone Hornemann; Olof Harlin; Caroline Staib; Sigrid Kisling; Volker Erfle; Bernd Kaspers; Georg Häcker; Gerd Sutter
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

9.  Newcastle disease virus V protein is associated with viral pathogenesis and functions as an alpha interferon antagonist.

Authors:  Zhuhui Huang; Sateesh Krishnamurthy; Aruna Panda; Siba K Samal
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

10.  Characterization of influenza virus variants with different sizes of the non-structural (NS) genes and their potential as a live influenza vaccine in poultry.

Authors:  L Wang; D L Suarez; M Pantin-Jackwood; M Mibayashi; A García-Sastre; Y M Saif; C-W Lee
Journal:  Vaccine       Date:  2008-05-22       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.